{"AllianceGenome": "42400", "HGNC": "42400", "MIM": "613714", "_id": "374383", "_version": 1, "accession": {"genomic": ["AC124798.5", "CP068267.2", "KC877395.1", "NC_000011.10", "NC_060935.1"], "protein": ["CAD97811.1", "CAH18335.1", "NP_001189368.1", "Q68D85.1", "XP_011518376.1", "XP_011518377.1", "XP_047282862.1"], "rna": ["BC136797.1", "BC136800.1", "BX537685.1", "CR749521.1", "NM_001009913.1", "NM_001202439.3", "NR_026750.1", "XM_011520074.4", "XM_011520075.4", "XM_047426906.1"], "translation": [{"protein": "CAH18335.1", "rna": "CR749521.1"}, {"protein": "XP_047282862.1", "rna": "XM_047426906.1"}, {"protein": "XP_011518376.1", "rna": "XM_011520074.4"}, {"protein": "XP_011518377.1", "rna": "XM_011520075.4"}, {"protein": "CAD97811.1", "rna": "BX537685.1"}, {"protein": "NP_001189368.1", "rna": "NM_001202439.3"}]}, "alias": ["B7-H6", "B7H6", "DKFZp686O24166"], "ensembl": {"gene": "ENSG00000188211", "protein": ["ENSP00000341637", "ENSP00000434394"], "transcript": ["ENST00000338965", "ENST00000530403"], "translation": [{"protein": "ENSP00000341637", "rna": "ENST00000338965"}, {"protein": "ENSP00000434394", "rna": "ENST00000530403"}], "type_of_gene": "protein_coding"}, "entrezgene": "374383", "exons": [{"cdsend": 17372512, "cdsstart": 17351969, "chr": "11", "position": [[17351799, 17352039], [17356650, 17357001], [17367008, 17367347], [17368866, 17368964], [17372005, 17377324]], "strand": 1, "transcript": "NM_001202439", "txend": 17377324, "txstart": 17351799}], "exons_hg19": [{"cdsend": 17394059, "cdsstart": 17373516, "chr": "11", "position": [[17373346, 17373586], [17378197, 17378548], [17388555, 17388894], [17390413, 17390511], [17393552, 17398871]], "strand": 1, "transcript": "NM_001202439", "txend": 17398871, "txstart": 17373346}], "generif": [{"pubmed": 19528259, "text": "DKFZp686O24166 was designated the gene B7-H6; identification as a tumor cell surface molecule that binds NKp30, a receptor which triggers antitumor NK cell cytotoxicity and cytokine secretion"}, {"pubmed": 21422170, "text": "The NKp30-B7-H6 structure revealed that this NK cell activating complex is distinct from the CTLA4-B7 and PD-1-PD-L T cell inhibitory complexes in both overall organization and detailed atomic interactions that mediate binding and specificity."}, {"pubmed": 23066150, "text": "B7-H6:7D8 represents the first Ab-based molecule stimulating NKp30-mediated NK cell cytotoxicity for therapeutic purposes"}, {"pubmed": 23687088, "text": "These findings reveal that B7-H6 is not only implicated in tumor immunosurveillance but also participates in the inflammatory response in infectious conditions."}, {"pubmed": 24242703, "text": "B7-H6-positive carcinomas were significantly associated with a higher differentiation."}, {"pubmed": 24275655, "text": "Data indicate that the ectodomain of NKp30 forms functional homo-oligomers that mediate high affinity binding to its corresponding cellular ligand B7-H6."}, {"pubmed": 24780758, "text": "this study identified ectodomain shedding of B7-H6 by the metalloproteases \"a disintegrin and metalloproteases\" (ADAM)-10 and ADAM-17 from the cell surface of tumor cells as a crucial mechanism of expression regulation of B7-H6."}, {"pubmed": 25001651, "text": "Allogeneic and xenogeneic anti-tumor effect of callithrix jacchus natural killer cells is dependent on NKp30 and B7-H6 interaction."}, {"pubmed": 25400778, "text": "Study suggests that B7-H6 has a limited value as a prognostic marker in non-small cell lung cancer patients."}, {"pubmed": 25877893, "text": "the interaction between NKp30 and B7-H6 may contribute to the fate of neuroblastoma patients"}, {"pubmed": 26241657, "text": "Our results suggest that NKP30-B7-H6 interaction can aggravate hepatocyte damage, probably through up-regulation of IL-32 expression in hepatitis B virus-related acute-on-chronic liver failure"}, {"pubmed": 26464699, "text": "our present data revealed that higher B7-H6 expression in ovarian cancer tissues was positively correlated with tumor metastasis and cancer progression"}, {"pubmed": 26472927, "text": "study not only reveals the possibility that tumor therapeutics work as stress inducers to enhance tumor sensitivity to NK cell cytolysis but also suggests that B7-H6 could be a potential target for tumor therapy in the future"}, {"pubmed": 26582946, "text": "NKp30-B7-H6 interaction is a novel cell contact mechanism that mediates activation of Group 2 innate lymphoid cells and identifies a potential target for the development of novel therapeutics for atopic dermatitis and other atopic diseases."}, {"pubmed": 26891663, "text": "Study confirms that B7-H6 is widely expressed in B-cell lymphomas and demonstrates its important role in the pathogenesis and chemosensitivity of lymphoma."}, {"pubmed": 27216712, "text": "B7H6-derived peptides trigger TNF-alpha-dependent immunostimulatory activity of lymphocytic NK92-MI cells."}, {"pubmed": 28415577, "text": "Data suggest that B7-H6 play an important role in the regulation of the biological behavior of glioma cells."}, {"pubmed": 28928446, "text": "Data indicate a sequence of events driven by tumour-derived prostaglandin D2 (PGD2) associated with engagement of the natural cytotoxicity triggering receptor 3 (NKp30)-B7H6 antigen (B7H6) pathway leading to significant group 2 innate lymphoid cells (ILC2s) activation and expansion."}, {"pubmed": 29055565, "text": "these studies find that soluble B7H6 is constitutively expressed during pregnancy"}, {"pubmed": 29679856, "text": "B7-H6 was expressed in gliomas and correlated with glioma progression. Knockdown of B7-H6 inhibited glioma cell proliferation, colony formation, migration, and invasion via upregulation of E-cadherin and Bax, and downregulation of vimentin, N-cadherin, MMP-2, MMP-9 and survivin."}, {"pubmed": 30325780, "text": "Altogether, these data suggested that the defective expression of NKp30 may be induced by the chronic engagement of this receptor by B7-H6 expressed on HIV-2-infected target cells. This represents a novel mechanism by which the chronic ligand exposure by the viral environment may subvert NK-cell-mediated function to establish persistent HIV-2 infection."}, {"pubmed": 31792298, "text": "The prognostic value of B7-H6 in esophageal squamous cell carcinoma."}, {"pubmed": 31904350, "text": "Immunological role and underlying mechanisms of B7-H6 in tumorigenesis."}, {"pubmed": 32138659, "text": "Positive staining of the immunoligand B7-H6 in abnormal/transformed keratinocytes consistently accompanies the progression of cervical cancer."}, {"pubmed": 32322592, "text": "Preferential Expression of B7-H6 in Glioma Stem-Like Cells Enhances Tumor Cell Proliferation via the c-Myc/RNMT Axis."}, {"pubmed": 33220098, "text": "Dual role of B7-H6 as a novel prognostic marker in hepatocellular carcinoma."}, {"pubmed": 33483421, "text": "Large remodeling of the Myc-induced cell surface proteome in B cells and prostate cells creates new opportunities for immunotherapy."}, {"pubmed": 33523715, "text": "NCR3LG1 (B7-H6) is a potential prognostic factor for bladder cancer patients."}, {"pubmed": 33671836, "text": "Secreted Ligands of the NK Cell Receptor NKp30: B7-H6 Is in Contrast to BAG6 Only Marginally Released via Extracellular Vesicles."}, {"pubmed": 33824367, "text": "Immune checkpoint molecules B7-H6 and PD-L1 co-pattern the tumor inflammatory microenvironment in human breast cancer."}, {"pubmed": 34280008, "text": "B7-H6 as a Diagnostic Biomarker for Cervical Squamous Cell Carcinoma."}, {"pubmed": 36692844, "text": "B7-H6 enhances F-actin rearrangement by targeting c-MYC activation to promote medulloblastoma migration and invasion."}, {"pubmed": 37053079, "text": "B7H6 silencing increases chemosensitivity to dacarbazine and suppresses cell survival and migration in cutaneous melanoma."}], "genomic_pos": {"chr": "11", "end": 17377341, "ensemblgene": "ENSG00000188211", "start": 17351800, "strand": 1}, "genomic_pos_hg19": {"chr": "11", "end": 17398888, "start": 17373273, "strand": 1}, "go": {"BP": [{"evidence": "IBA", "gocategory": "BP", "id": "GO:0006958", "qualifier": "involved_in", "term": "complement activation, classical pathway"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0019731", "qualifier": "involved_in", "term": "antibacterial humoral response"}], "CC": [{"evidence": "TAS", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0042571", "qualifier": "part_of", "term": "immunoglobulin complex, circulating"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0003823", "qualifier": "enables", "term": "antigen binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [19528259, 21422170, 21444796, 22807449, 24275655, 27754869, 32296183], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0034987", "qualifier": "enables", "term": "immunoglobulin receptor binding"}]}, "homologene": {"genes": [[9598, 451055], [9606, 374383]], "id": 136462}, "interpro": [{"desc": "Immunoglobulin/major histocompatibility complex, conserved site", "id": "IPR003006", "short_desc": "Ig/MHC_CS"}, {"desc": "Immunoglobulin C1-set", "id": "IPR003597", "short_desc": "Ig_C1-set"}, {"desc": "Immunoglobulin subtype", "id": "IPR003599", "short_desc": "Ig_sub"}, {"desc": "Immunoglobulin-like domain", "id": "IPR007110", "short_desc": "Ig-like_dom"}, {"desc": "Retroviral matrix protein", "id": "IPR010999", "short_desc": "Retrovr_matrix"}, {"desc": "Immunoglobulin-like fold", "id": "IPR013783", "short_desc": "Ig-like_fold"}, {"desc": "Immunoglobulin-like domain superfamily", "id": "IPR036179", "short_desc": "Ig-like_dom_sf"}, {"desc": "Gamma-retroviral matrix domain superfamily", "id": "IPR036946", "short_desc": "G_retro_matrix_sf"}], "ipi": "IPI00398918", "map_location": "11p15.1", "name": "natural killer cell cytotoxicity receptor 3 ligand 1", "other_names": ["B7 homolog 6", "natural cytotoxicity triggering receptor 3 ligand 1", "putative Ig-like domain-containing protein DKFZp686O24166/DKFZp686I21167"], "pantherdb": {"HGNC": "42400", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"Ensembl": "ENSGALG00000051946", "ortholog_type": "O", "panther_family": "PTHR23411", "taxid": 9031, "uniprot_kb": "A0A3Q2U0E4"}, {"Gene": "IGHM_CHICK", "ortholog_type": "O", "panther_family": "PTHR23411", "taxid": 9031, "uniprot_kb": "P01875"}, {"ZFIN": "ZDB-GENE-040513-8", "ortholog_type": "O", "panther_family": "PTHR23411", "taxid": 7955, "uniprot_kb": "M9MMF2"}, {"ZFIN": "ZDB-GENE-040513-9", "ortholog_type": "O", "panther_family": "PTHR23411", "taxid": 7955, "uniprot_kb": "M9MMF9"}], "uniprot_kb": "Q68D85"}, "pathway": {"reactome": [{"id": "R-HSA-1280218", "name": "Adaptive Immune System"}, {"id": "R-HSA-168256", "name": "Immune System"}, {"id": "R-HSA-198933", "name": "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"}]}, "pdb": ["3PV6", "3PV7", "4ZSO", "6YJP"], "pfam": "PF07654", "pharmgkb": "PA166049084", "pharos": {"target_id": 18744, "tdl": "Tbio"}, "prosite": "PS50835", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF175999", "relationship": "is"}, {"id": "GNF186905", "relationship": "is"}, {"id": "GNF197811", "relationship": "is"}, {"id": "GNF208717", "relationship": "is"}, {"id": "GNF223799", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000011.10", "NC_060935.1"], "protein": ["NP_001189368.1", "XP_011518376.1", "XP_011518377.1", "XP_047282862.1"], "rna": ["NM_001009913.1", "NM_001202439.3", "NR_026750.1", "XM_011520074.4", "XM_011520075.4", "XM_047426906.1"], "translation": [{"protein": "XP_011518377.1", "rna": "XM_011520075.4"}, {"protein": "NP_001189368.1", "rna": "NM_001202439.3"}, {"protein": "XP_047282862.1", "rna": "XM_047426906.1"}, {"protein": "XP_011518376.1", "rna": "XM_011520074.4"}]}, "reporter": {"HG-U133_Plus_2": "229715_at", "HG-U95B": ["43752_at", "46881_at"], "HTA-2_0": ["TC11000229.hg.1", "TC11002579.hg.1"], "HuEx-1_0": "3322307", "HuGene-1_1": "7938702", "HuGene-2_1": "16722445"}, "retired": 107984316, "summary": "B7H6 belongs to the B7 family (see MIM 605402) and is selectively expressed on tumor cells. Interaction of B7H6 with NKp30 (NCR3; MIM 611550) results in natural killer (NK) cell activation and cytotoxicity (Brandt et al., 2009 [PubMed 19528259]).[supplied by OMIM, Jan 2011].", "symbol": "NCR3LG1", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C3150976"}, "unigene": "Hs.146274", "uniprot": {"Swiss-Prot": "Q68D85"}}